Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CervoMed Inc.DFFN · Entity 7338 | General Counsel | January 07, 2020 | January 09, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CervoMed Inc.
Report date January 07, 2020 · Filed January 09, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.42 · Expires 2022-12-31 | Direct | 25,000 |
Reported balance
After 2020-01-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-01-07 · Grant · Acquired 25,000 · Balance 25,000 F1: The shares underlying the options vest in 36 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a three-year period beginning on January 1, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares underlying the options vest in 36 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a three-year period beginning on January 1, 2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 07, 2020 Filed Jan 9, 2020 22:03 UTC | CervoMed Inc. DFFN · Entity 7338 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001437749-20-000403 · rdgdoc.xml · derivative · entry 1 Byrne Thomas E · CIK 0001663220 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2022-12-31 F1 · derivative.exercise_date: The shares underlying the options vest in 36 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a three-year period beginning on January 1, 2020. Read SEC document |
| January 03, 2019 Filed Jan 30, 2019 14:06 UTC | CervoMed Inc. DFFN · Entity 7338 | GrantStock Option (Right to Buy) · Derivative | 2,667 | $0.00 Strike: $2.10 | $0.00 |
DisclosureSEC source: 0001437749-19-001522 · rdgdoc.xml · derivative · entry 1 Byrne Thomas E · CIK 0001663220 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,667 Underlying: Common Stock · 2,667 shares Expires 2029-01-02 F1 · derivative.exercise_date: The shares underlying the options vest in 36 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a three-year period beginning on January 31, 2019. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:03 UTC | CervoMed Inc. DFFN · Entity 7338 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0001437749-18-000264 · rdgdoc.xml · derivative · entry 1 Byrne Thomas E · CIK 0001663220 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2028-01-02 F1 · derivative.exercise_date: The shares underlying the options vest in 36 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a three-year period beginning on January 31, 2018. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 21:15 UTC | CervoMed Inc. DFFN · Entity 7338 | GrantStock Option (Right to Buy) · Derivative | 4,673 | $0.00 Strike: $2.26 | $0.00 |
DisclosureSEC source: 0001437749-17-000152 · rdgdoc.xml · derivative · entry 1 Byrne Thomas E · CIK 0001663220 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,673 Underlying: Common Stock · 4,673 shares Expires 2027-01-03 F1 · derivative.exercise_date: The shares underlying the options vest in equal parts on the last calendar day of each month until fully vested on December 31, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.